Through direct targeting NF-κB, ectopic expression of miR-9 inhibits the in vitro and in vivo growth of ovarian cancer cells [31] and the growth and metastasis of melanoma [32]. This evidence concerns the gene NFKB1 and ovarian carcinoma.